
ChrisChrisW/iStock via Getty Images
Seres Therapeutics jumped 21% in premarket trading after a report that Nestle made a takeover offer of ~$760 million for the company.
The $41 a share all-cash offer was valid until the end of August, according to Swiss blog Inside